[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1100848A1 - Anti-human tenascin monoclonal antibody - Google Patents

Anti-human tenascin monoclonal antibody

Info

Publication number
HK1100848A1
HK1100848A1 HK07108522.3A HK07108522A HK1100848A1 HK 1100848 A1 HK1100848 A1 HK 1100848A1 HK 07108522 A HK07108522 A HK 07108522A HK 1100848 A1 HK1100848 A1 HK 1100848A1
Authority
HK
Hong Kong
Prior art keywords
monoclonal antibody
human tenascin
tenascin monoclonal
human
antibody
Prior art date
Application number
HK07108522.3A
Other languages
English (en)
Inventor
R De Santis
A Pelliccia
G Palombo
P Carminati
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of HK1100848A1 publication Critical patent/HK1100848A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
HK07108522.3A 2004-02-27 2007-08-06 Anti-human tenascin monoclonal antibody HK1100848A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000105A ITRM20040105A1 (it) 2004-02-27 2004-02-27 Anticorpo monoclonale antitenascina umana.
PCT/IT2005/000078 WO2005082938A2 (en) 2004-02-27 2005-02-16 Anti-human tenascin monoclonal antibody

Publications (1)

Publication Number Publication Date
HK1100848A1 true HK1100848A1 (en) 2007-09-28

Family

ID=34897820

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07108522.3A HK1100848A1 (en) 2004-02-27 2007-08-06 Anti-human tenascin monoclonal antibody

Country Status (16)

Country Link
US (1) US7989171B2 (es)
EP (1) EP1718678B1 (es)
JP (1) JP5191036B2 (es)
KR (1) KR101266389B1 (es)
CN (1) CN1946740B (es)
AR (1) AR047819A1 (es)
AU (1) AU2005217237B2 (es)
BR (1) BRPI0508082A8 (es)
CA (1) CA2558718C (es)
ES (1) ES2654065T3 (es)
HK (1) HK1100848A1 (es)
IT (1) ITRM20040105A1 (es)
MX (1) MXPA06009674A (es)
PL (1) PL1718678T3 (es)
PT (1) PT1718678T (es)
WO (1) WO2005082938A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ561361A (en) 2005-02-11 2010-02-26 Amylin Pharmaceuticals Inc GIP hybrid polypeptides with at least two hormonal activities
US8263545B2 (en) 2005-02-11 2012-09-11 Amylin Pharmaceuticals, Inc. GIP analog and hybrid polypeptides with selectable properties
JP2012031084A (ja) * 2010-07-29 2012-02-16 Tokyo Univ Of Science 抗腫瘍剤
WO2014113459A1 (en) * 2013-01-15 2014-07-24 Duke University Hiv-1 neutralizing factor
US20160097771A1 (en) * 2013-05-21 2016-04-07 NX Pharmagen Use of tenascin-c as an extracellular marker of tumor-derived microparticles
GB201616596D0 (en) * 2016-09-29 2016-11-16 Nascient Limited Epitope and antibodies
WO2023240135A2 (en) 2022-06-07 2023-12-14 Actinium Pharmaceuticals, Inc. Bifunctional chelators and conjugates

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5634076A (en) * 1994-10-04 1997-05-27 Analog Devices, Inc. DMA controller responsive to transition of a request signal between first state and second state and maintaining of second state for controlling data transfer
US6014709A (en) * 1997-11-05 2000-01-11 Unisys Corporation Message flow protocol for avoiding deadlocks
US6335014B1 (en) * 1998-06-17 2002-01-01 The Institute Of Physical And Chemical Research Medicament for suppressing cancer metastasis
US6521593B1 (en) * 1999-02-01 2003-02-18 Childrens Hospital Los Angeles Methods for inhibiting brain tumor growth
JP2003512300A (ja) * 1999-05-01 2003-04-02 ユニバーシティー オブ メディシン アンド デンティストリー オブ ニュー ジャージー テネイシンｃによる軸索突起の伸長及び誘導
US7058750B1 (en) * 2000-05-10 2006-06-06 Intel Corporation Scalable distributed memory and I/O multiprocessor system
JP3646159B2 (ja) * 2001-02-08 2005-05-11 国立大学法人三重大学 抗テネイシンｃモノクローナル抗体及び当該抗体を産生するハイブリドーマ
ITRM20010079A1 (it) * 2001-02-16 2002-08-16 Sigma Tau Ind Farmaceuti Amminoderivati della biotina e loro coniugati con chelanti macrociclici.
US7438908B2 (en) * 2002-02-26 2008-10-21 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Anti-human tenascin monoclonal antibody
ITRM20020128A1 (it) * 2002-03-08 2003-09-08 Sigma Tau Ind Farmaceuti Dimeri di avidina efficaci nell'incrementare la concentrazione di biotina radioattiva nella immunoterapia con "pretargeting".

Also Published As

Publication number Publication date
KR101266389B1 (ko) 2013-05-28
BRPI0508082A (pt) 2007-07-17
ITRM20040105A1 (it) 2004-05-27
WO2005082938A2 (en) 2005-09-09
JP5191036B2 (ja) 2013-04-24
AU2005217237B2 (en) 2011-12-22
AU2005217237A1 (en) 2005-09-09
KR20070002029A (ko) 2007-01-04
CA2558718A1 (en) 2005-09-09
PT1718678T (pt) 2017-12-29
US20100297003A1 (en) 2010-11-25
ES2654065T3 (es) 2018-02-12
CN1946740A (zh) 2007-04-11
BRPI0508082A8 (pt) 2017-12-26
US7989171B2 (en) 2011-08-02
CA2558718C (en) 2015-01-13
EP1718678A2 (en) 2006-11-08
JP2008506355A (ja) 2008-03-06
CN1946740B (zh) 2012-09-05
MXPA06009674A (es) 2007-03-21
WO2005082938A3 (en) 2005-12-15
EP1718678B1 (en) 2017-10-11
PL1718678T3 (pl) 2018-05-30
AR047819A1 (es) 2006-02-22

Similar Documents

Publication Publication Date Title
IL272883A (en) Monoclonal antibodies and their uses
HK1078589A1 (en) Anti-human tenascin monoclonal antibody
IL206709A0 (en) Il-31 monoclonal antibodies
SG10201404801YA (en) Monoclonal antibody
IL191217A (en) Anti-17 mantle monoclonal antibody
IL180152A0 (en) Chimeric and humanised monoclonal antibodies against inteleukin-13
IL176755A0 (en) M-csf-specific monoclonal antibody and uses thereof
IL184152A0 (en) Monoclonal antibodies against nkg2a
IL179672A0 (en) Anti-cd3 antibodies
ZA200909185B (en) Antagonistic anti-human cd40 monoclonal antibody
IL187710A0 (en) Anti-trkb monoclonal antibodies and uses thereof
IL190502A0 (en) Anti-addl monoclonal antibody and use thereof
HK1102760A1 (en) Anti-psgl-1 antibodies
EP1717250A4 (en) MONOCLONAL ANTIBODY AND ITS USE
EP1761566A4 (en) HUMANIZED MONOCLONAL ANTIBODIES ANTI-TAG-72
HK1100848A1 (en) Anti-human tenascin monoclonal antibody
ZA200706185B (en) Monoclonal antibodies against NKG2A
EP1718749A4 (en) ANTI-AF-20 HUMANIZED MONOCLONAL ANTIBODY
EP1712564A4 (en) MONOCLONAL ANTIBODY ANTI-NC1
GB0415644D0 (en) Monoclonal antibody
IL165753A0 (en) Humanized monoclonal antibody nPAM4

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200216